Equity and Capital - Forward Equity Sale (Details) - USD ($) $ in Millions		12 Months Ended
	Sep. 13, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		12,824,000	12,343,000	18,460,000
Underwritten Public Offering
Class of Stock [Line Items]
Issuance of common stock, net of costs (shares)	6.3	6,300,000
Gross proceeds		$ 939.0